Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Mar 2022 | Mar 2021 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
1.68B | 1.89B | 2.11B | 2.18B | 1.86B | Gross Profit |
1.00B | 1.09B | 1.20B | 1.32B | 1.16B | EBIT |
22.87M | 22.94M | 67.88M | 193.54M | 184.90M | EBITDA |
89.22M | 95.34M | 135.28M | 253.93M | 246.46M | Net Income Common Stockholders |
-20.33M | -15.29M | 36.61M | 153.75M | 139.19M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
1.95M | 2.54M | 1.79M | 2.39M | 4.24M | Total Assets |
860.81M | 950.88M | 953.94M | 919.54M | 800.14M | Total Debt |
936.11M | 972.65M | 896.01M | 791.05M | 589.36M | Net Debt |
934.16M | 970.12M | 894.22M | 788.66M | 585.12M | Total Liabilities |
1.31B | 1.39B | 1.39B | 1.34B | 1.02B | Stockholders Equity |
-451.59M | -441.93M | -438.18M | -424.95M | -223.98M |
Cash Flow | Free Cash Flow | |||
3.64M | -66.08M | -33.32M | 233.11M | 240.59M | Operating Cash Flow |
27.14M | -9.03M | 36.14M | 300.01M | 279.66M | Investing Cash Flow |
-26.29M | -58.35M | -70.61M | -66.64M | -39.02M | Financing Cash Flow |
-1.44M | 68.13M | 33.87M | -235.22M | -237.99M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
73 Outperform | $722.97M | 11.92 | 12.86% | 5.42% | -11.10% | -23.77% | |
72 Outperform | $1.63B | 13.54 | 12.40% | 2.10% | 1.81% | 8.09% | |
66 Neutral | $271.31M | 30.53 | 5.33% | ― | -2.80% | -49.06% | |
60 Neutral | $6.58B | 11.55 | 3.14% | 4.05% | 2.58% | -21.37% | |
52 Neutral | $1.11B | 38.62 | 2.28% | 4.51% | -2.68% | -56.16% | |
44 Neutral | $176.52M | ― | 9.10% | ― | -10.87% | -33.24% | |
38 Underperform | $73.36M | ― | -144.37% | ― | -5.48% | 17.33% |
On April 25, 2025, Sleep Number Corporation eliminated the role of Executive Vice President and Chief Innovation Officer, previously held by Annie Bloomquist, as part of a broader organizational redesign. Bloomquist will serve in an advisory role until May 31, 2025, to aid in the transition. The company announced changes to its Executive Leadership Team to enhance efficiency and accountability, with new roles and responsibilities aimed at strengthening company performance and improving customer engagement. These changes are intended to streamline decision-making and better position the company to respond to industry and macroeconomic shifts.
Spark’s Take on SNBR Stock
According to Spark, TipRanks’ AI Analyst, SNBR is a Neutral.
Sleep Number’s overall stock score reflects significant financial challenges, especially negative profitability and high leverage. The weak technical indicators and unattractive valuation further weigh down the score. While the earnings call and new CEO appointment offer some positive developments, they are not sufficient to offset the primary concerns.
To see Spark’s full report on SNBR stock, click here.
On April 16, 2025, Sleep Number Corporation announced it will release its fiscal first quarter results for 2025 on April 30, 2025, after market close. The company will host a conference call to discuss these results, providing stakeholders with insights into its financial performance and strategic direction.
Spark’s Take on SNBR Stock
According to Spark, TipRanks’ AI Analyst, SNBR is a Neutral.
Sleep Number’s stock faces significant challenges due to financial instability, negative profitability, and weak market sentiment. While operational improvements and cost management provide some positives, they are overshadowed by declining sales and economic pressures. The appointment of a new CEO may offer a strategic shift, but current market conditions and valuation concerns weigh heavily on the stock’s attractiveness.
To see Spark’s full report on SNBR stock, click here.
On March 5, 2025, Sleep Number Corporation announced the appointment of Linda Findley as President, CEO, and Director, effective April 7, 2025. Following a significant decline in the company’s stock price after reporting its 2024 financial results, an amendment to Findley’s offer letter was made on March 31, 2025, to restructure her equity inducement grant. The amendment aims to mitigate shareholder dilution by using a notional share price based on the average closing price in 2024 and includes additional performance metrics for vesting conditions. The amendment also introduces a cash sign-on bonus, part of which Findley will use to purchase company stock, aligning her interests with those of the shareholders.
On March 13, 2025, Sleep Number Corporation announced an agreement with its largest shareholder, Stadium Capital Management, to restructure its Board of Directors. This agreement involves the retirement of five current board members, including Michael J. Harrison and Barbara R. Matas, as part of a strategy to refresh and reduce the board’s size. The restructuring aims to enhance the company’s agility and focus on strengthening performance amid challenging market conditions. The company appreciates the contributions of the retiring directors and looks forward to working with the refreshed board to drive Sleep Number’s transformation and growth.
On February 18, 2025, Sleep Number Corporation announced its upcoming fiscal fourth quarter and full year 2024 earnings results release and conference call scheduled for March 5, 2025. The announcement is significant for stakeholders as it provides insights into the company’s financial health and operational performance, potentially impacting market perceptions and investor decisions.